On December 31, Jazz Pharmaceuticals (JAZZ) had a market capitalization of $7.6B, based on 61.5M shares at a price of $123.15.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
December 2024 | $123.15 | 12,439,900 | 61,503,000 | $7,574,094,450.00 |
November 2024 | $121.59 | 14,519,300 | 61,503,000 | $7,478,149,770.00 |
October 2024 | $110.03 | 11,872,100 | 61,503,000 | $6,767,175,090.00 |
September 2024 | $111.41 | 18,516,800 | 63,174,000 | $7,038,215,340.00 |
August 2024 | $115.98 | 12,505,200 | 63,174,000 | $7,326,920,520.00 |
July 2024 | $110.25 | 11,959,500 | 63,174,000 | $6,964,933,500.00 |
June 2024 | $106.73 | 16,442,000 | 69,625,000 | $7,431,076,250.00 |
May 2024 | $105.25 | 19,851,000 | 69,625,000 | $7,328,031,250.00 |
April 2024 | $110.75 | 11,965,600 | 69,625,000 | $7,710,968,750.00 |
March 2024 | $120.42 | 15,081,500 | 62,537,000 | $7,530,705,540.00 |
February 2024 | $118.90 | 10,656,000 | 62,537,000 | $7,435,649,300.00 |
January 2024 | $122.72 | 12,656,700 | 62,537,000 | $7,674,540,640.00 |
December 2023 | $123.00 | 12,365,300 | 69,673,000 | $8,569,779,000.00 |
November 2023 | $118.23 | 17,053,200 | 69,673,000 | $8,237,438,790.00 |
October 2023 | $127.02 | 15,994,000 | 69,673,000 | $8,849,864,460.00 |
September 2023 | $129.44 | 9,366,200 | 71,293,000 | $9,228,165,920.00 |
August 2023 | $143.36 | 11,833,200 | 71,293,000 | $10,220,564,480.00 |
July 2023 | $130.42 | 8,995,400 | 71,293,000 | $9,298,033,060.00 |
June 2023 | $123.97 | 14,221,200 | 73,540,000 | $9,116,753,800.00 |
May 2023 | $128.16 | 12,837,000 | 73,540,000 | $9,424,886,400.00 |
April 2023 | $140.47 | 6,737,700 | 73,540,000 | $10,330,163,800.00 |
March 2023 | $146.33 | 12,910,600 | 73,771,000 | $10,794,910,430.00 |
February 2023 | $140.40 | 10,818,300 | 73,771,000 | $10,357,448,400.00 |
January 2023 | $156.66 | 9,135,200 | 73,771,000 | $11,556,964,860.00 |
December 2022 | $159.31 | 13,850,500 | 63,052,000 | $10,044,814,120.00 |
